Is this you? Create Your Porfile
Avatar

Juergen Prof Dr Zapf

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Juergen Prof Dr Zapf is active.

Explore More

Publication

Featured researches published by Juergen Prof Dr Zapf.

FEBS Journal | 1980

Increased Sensitivity to Lipolytic Hormones of Adenylate Cyclase in Fat Cells of Diabetic Rats

Peter Zumstein; Juergen Prof Dr Zapf; Margaretha Waldvogel; E. Rudolf Froesch

Endocrinology | 1983

Regulation of rat adipocyte glucose transport by growth hormone: no mediation by insulin-like growth factors.

Eugen J. Schoenle; Juergen Prof Dr Zapf; E. Rudolf Froesch

Archive | 1989

Use of IGF-I for the manufacture of a preparation for the treatment and the prevention of side effects of hyperinsulinemia in diabetics treated with insulin.

Ernst Rudolf Prof Dr Froesch; Hans-Peter Guler; Christoph Schmid; Juergen Prof Dr Zapf

Archive | 1989

Verwendung von igf i zur herstellung eines praeparates fuer die behandlung von nierenkrankheiten.

Ernst Rudolf Prof Dr Froesch; Hans-Peter Guler; Christoph Schmid; Juergen Prof Dr Zapf

Archive | 1989

Verwendung von igf i zur herstellung eines praeparates fuer die behandlung von nierenkrankheiten. Use of IGF I for the manufacture of a preparation for the treatment of renal disease.

Ernst Rudolf Prof Dr Froesch; Hans-Peter Guler; Christoph Schmid; Juergen Prof Dr Zapf

Archive | 1989

Verwendung von igf-i zur herstellung eines praeparats fuer die behandlung und die verhuetung von nebeneffekten von hyperinsulinemia bei diabetikern behandelt mit insulin. Using igf-i for preparing a preparation for the treatment and prevention of side effects of hyperinsulinemia in diabetics treated with insulin.

Ernst Rudolf Prof Dr Froesch; Hans-Peter Guler; Christoph Schmid; Juergen Prof Dr Zapf

Archive | 1989

Medicinal preparation for treating nephropathy

Ernst Rudolf Prof Dr Froesch; Hans-Peter Guler; Christoph Schmid; Juergen Prof Dr Zapf

Archive | 1989

An agent for the treatment of kidney diseases

Ernst Rudolf Prof Dr Froesch; Hans-Peter Guler; Christoph Schmid; Juergen Prof Dr Zapf

Archive | 1989

Use of IGF I for the manufacture of a preparation for the treatment of renal disease.

Ernst Rudolf Prof Dr Froesch; Hans-Peter Guler; Christoph Schmid; Juergen Prof Dr Zapf

Archive | 1989

Verwendung von igf-i zur herstellung eines praeparats fuer die behandlung und die verhuetung von nebeneffekten von hyperinsulinemia bei diabetikern behandelt mit insulin.

Ernst Rudolf Prof Dr Froesch; Hans-Peter Guler; Christoph Schmid; Juergen Prof Dr Zapf

Explore More

Collaboration

Dive into the Juergen Prof Dr Zapf's collaboration.

Top Co-Authors
Avatar

Ernst Rudolf Prof Dr Froesch

Novartis

View shared research outputs
Top Co-Authors
Avatar

Christoph Schmid

University of Connecticut

View shared research outputs
Top Co-Authors
Avatar

Hans-Peter Guler

University of Connecticut

View shared research outputs
Top Co-Authors
Avatar

E. Rudolf Froesch

University of Zurich

View shared research outputs
Top Co-Authors
Avatar

Eugen J. Schoenle

Boston Children's Hospital

View shared research outputs
Top Co-Authors
Avatar

Christoph Schmid

University of Connecticut

View shared research outputs
Top Co-Authors
Avatar

Hans-Peter Guler

University of Connecticut

View shared research outputs
Top Co-Authors
Avatar

E. Rudolf Froesch

University of Zurich

View shared research outputs
Top Co-Authors
Avatar

Margaretha Waldvogel

University of Zurich

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge